Proper medication storage directly impacts treatment outcomes, as degraded medication may deliver subtherapeutic doses, potentially leading to inadequate glycemic control or insufficient weight management effects
However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower
Amgen's MariTide, which combines GLP-1 agonism with GIP antagonism, was specifically designed based on genetic evidence suggesting this combination could reduce nausea while maintaining weight loss efficacy [44]
Aesthetic Surgery Journal
El estudio tambin encontr conexiones relacionadas con la dosis entre las concentraciones de L-carnitina en plasma en ayunas y el riesgo de enfermedad arterial coronaria, enfermedad arterial perifrica y enfermedad cardiovascular general, pero solo en los participantes que tenan altas concentraciones de TMAO
Genazzani AD, Petraglia F, Algeri I, et al
